2 resultados para 12.39.-x
em Universidad de Alicante
Resumo:
El período de más incidencia de la poliomielitis en España corresponde a los años de 1950 a 1963. La vacuna inactivada antipolio de Salk estuvo disponible a partir de 1955 y varios países la adoptaron para combatir la enfermedad. La actitud de las autoridades sanitarias españolas para abordar el problema fue tibia e ineficaz, sin dar una respuesta decidida para implementar la vacuna de modo sistemático. Hemos realizado un estudio de caso explorando las noticias sobre polio recogidas en dos semanarios de la provincia de Guadalajara durante el decenio de 1958–1967. Los resultados revelan una acumulación de informaciones sesgada y contradictoria, que refleja la incapacidad para tomar decisiones. Desde la negación de la enfermedad y las dudas sobre la vacuna Salk en el primer período, se pasa a la exaltación de la vacuna oral de Sabin, cuando ésta mostró su evidencia tras aplicarla en la campaña de 1963–1964, y que las autoridades se atribuyeron este éxito tardío con una fuerte propaganda mediática.
Resumo:
Liver X receptors (LXRs) are ligand-activated transcription factors of the nuclear receptor superfamily. They play important roles in controlling cholesterol homeostasis and as regulators of inflammatory gene expression and innate immunity, by blunting the induction of classical pro-inflammatory genes. However, opposite data have also been reported on the consequences of LXR activation by oxysterols, resulting in the specific production of potent pro-inflammatory cytokines and reactive oxygen species (ROS). The effect of the inflammatory state on the expression of LXRs has not been studied in human cells, and constitutes the main aim of the present work. Our data show that when human neutrophils are triggered with synthetic ligands, the synthesis of LXRα mRNA became activated together with transcription of the LXR target genes ABCA1, ABCG1 and SREBP1c. An inflammatory mediator, 15-deoxy-Δ12,14-prostaglandin J2 (15dPGJ2), hindered T0901317-promoted induction of LXRα mRNA expression together with transcription of its target genes in both neutrophils and human macrophages. This down-regulatory effect was dependent on the release of reactive oxygen species elicited by 15dPGJ2, since it was enhanced by pro-oxidant treatment and reversed by antioxidants, and was also mediated by ERK1/2 activation. Present data also support that the 15dPGJ2-induced serine phosphorylation of the LXRα molecule is mediated by ERK1/2. These results allow to postulate that down-regulation of LXR cellular levels by pro-inflammatory stimuli might be involved in the development of different vascular diseases, such as atherosclerosis.